Anne S. Hellkamp

15.3k total citations · 4 hit papers
177 papers, 10.3k citations indexed

About

Anne S. Hellkamp is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Anne S. Hellkamp has authored 177 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Cardiology and Cardiovascular Medicine, 31 papers in Surgery and 22 papers in Internal Medicine. Recurrent topics in Anne S. Hellkamp's work include Cardiac pacing and defibrillation studies (64 papers), Cardiac Arrhythmias and Treatments (58 papers) and Atrial Fibrillation Management and Outcomes (54 papers). Anne S. Hellkamp is often cited by papers focused on Cardiac pacing and defibrillation studies (64 papers), Cardiac Arrhythmias and Treatments (58 papers) and Atrial Fibrillation Management and Outcomes (54 papers). Anne S. Hellkamp collaborates with scholars based in United States, United Kingdom and Canada. Anne S. Hellkamp's co-authors include Michael O. Sweeney, Kerry L. Lee, Gervasio A. Lamas, Kenneth A. Ellenbogen, Arnold J. Greenspon, Roger A. Freedman, Daniel B. Mark, Gust H. Bardy, Jeanne E. Poole and Jill Anderson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Anne S. Hellkamp

173 papers receiving 10.0k citations

Hit Papers

Adverse Effect of Ventricular Pacing on Heart Failure and... 2002 2026 2010 2018 2003 2008 2002 2003 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
    2003 1.2k citations Michael O. Sweeney, Anne S. Hellkamp et al. Circulation profile →
  2. Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
    2008 979 citations Jeanne E. Poole, George Johnson et al. profile →
  3. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
    2002 646 citations Gervasio A. Lamas, Kerry L. Lee et al. profile →
  4. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
    2003 528 citations Taya V. Glotzer, Anne S. Hellkamp et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne S. Hellkamp United States 49 9.0k 1.7k 1.1k 733 710 177 10.3k
Jonas Bjerring Olesen Denmark 46 6.6k 0.7× 1.0k 0.6× 2.2k 2.0× 1.4k 1.9× 391 0.6× 158 9.8k
Michiel Rienstra Netherlands 49 9.6k 1.1× 910 0.5× 645 0.6× 804 1.1× 444 0.6× 251 11.3k
Laurent Fauchier France 44 5.9k 0.7× 686 0.4× 781 0.7× 906 1.2× 343 0.5× 322 6.7k
Mauro Moscucci United States 46 4.3k 0.5× 2.7k 1.7× 824 0.8× 431 0.6× 1.3k 1.8× 163 7.4k
Morten Lock Hansen Denmark 40 5.7k 0.6× 1.1k 0.7× 1.6k 1.5× 739 1.0× 272 0.4× 145 7.5k
John H. McAnulty United States 35 7.3k 0.8× 1.2k 0.7× 507 0.5× 641 0.9× 426 0.6× 115 8.4k
Shun Kohsaka Japan 37 4.1k 0.5× 2.1k 1.3× 354 0.3× 664 0.9× 1.1k 1.5× 429 6.4k
Jesper Lindhardsen Denmark 32 3.1k 0.3× 788 0.5× 923 0.9× 1.0k 1.4× 327 0.5× 65 6.7k
Islam Y. Elgendy United States 35 2.9k 0.3× 1.8k 1.1× 408 0.4× 790 1.1× 1.0k 1.4× 328 4.9k
Tami L. Bair United States 47 3.7k 0.4× 1.6k 1.0× 352 0.3× 1.5k 2.0× 618 0.9× 195 7.6k

Countries citing papers authored by Anne S. Hellkamp

Since Specialization
Citations

This map shows the geographic impact of Anne S. Hellkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne S. Hellkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne S. Hellkamp more than expected).

Fields of papers citing papers by Anne S. Hellkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne S. Hellkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne S. Hellkamp. The network helps show where Anne S. Hellkamp may publish in the future.

Co-authorship network of co-authors of Anne S. Hellkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Anne S. Hellkamp. A scholar is included among the top collaborators of Anne S. Hellkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne S. Hellkamp. Anne S. Hellkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrington, Josephine, Anne S. Hellkamp, John H. Alexander, et al.. (2022). Abstract 13168: Benefits of Apixaban Over Warfarin are Preserved Independent of Warfarin Time in Therapeutic Range: Insights From the AUGUSTUS Trial. Circulation. 146(Suppl_1).
2.
Swaminathan, Aparna, Anne S. Hellkamp, Megan L. Neely, et al.. (2022). Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry. Annals of the American Thoracic Society. 19(6). 981–990. 20 indexed citations
3.
Greene, Stephen J., Javed Butler, Anne S. Hellkamp, et al.. (2021). Abstract 8872: Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Circulation. 144(Suppl_1).
4.
Greene, Stephen J., Javed Butler, Anne S. Hellkamp, et al.. (2021). Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Journal of Cardiac Failure. 28(3). 370–384. 20 indexed citations
5.
6.
Glotzer, Taya V., Anne S. Hellkamp, Kerry L. Lee, & Gervasio A. Lamas. (2015). CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. Canadian Journal of Cardiology. 31(8). 1004–1011. 19 indexed citations
7.
Steinberg, Benjamin A., Anne S. Hellkamp, Yuliya Lokhnygina, et al.. (2014). Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial. Heart Rhythm. 11(6). 925–932. 55 indexed citations
8.
Breithardt, Günter, Helmut Baumgartner, Scott D. Berkowitz, et al.. (2014). Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. European Heart Journal. 35(47). 3377–3385. 128 indexed citations
9.
Diepen, Sean van, Anne S. Hellkamp, Manesh R. Patel, et al.. (2013). Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation. Circulation Heart Failure. 6(4). 740–747. 83 indexed citations
10.
Piccini, Jonathan P., Anne S. Hellkamp, David J. Whellan, et al.. (2013). Exercise Training and Implantable Cardioverter-Defibrillator Shocks in Patients With Heart Failure. JACC Heart Failure. 1(2). 142–148. 44 indexed citations
11.
Halperin, Jonathan L., Zachary T. Bloomgarden, Anne S. Hellkamp, et al.. (2012). Abstract 15544: Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial. Circulation. 126. 4 indexed citations
12.
Gharacholou, S. Michael, Anne S. Hellkamp, Adrian F. Hernandez, et al.. (2011). Use and Predictors of Heart Failure Disease Management Referral in Patients Hospitalized With Heart Failure: Insights From the Get With the Guidelines Program. Journal of Cardiac Failure. 17(5). 431–439. 17 indexed citations
13.
Moore, H. J., Ross D. Fletcher, Robin Boineau, et al.. (2011). SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH OVERALL MORTALITY. Journal of the American College of Cardiology. 57(14). E41–E41. 1 indexed citations
14.
Packer, Douglas L., Jordan M. Prutkin, Anne S. Hellkamp, et al.. (2009). Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure. Circulation. 120(22). 2170–2176. 170 indexed citations
15.
Poole, Jeanne E., George Johnson, Anne S. Hellkamp, et al.. (2006). AB19-5. Heart Rhythm. 3(5). S40–S40. 6 indexed citations
16.
Greenspon, Arnold J., Robert G. Hart, David M. Dawson, et al.. (2004). Predictors of stroke in patients paced for sick sinus syndrome. Journal of the American College of Cardiology. 43(9). 1617–1622. 40 indexed citations
17.
Link, Mark S., Anne S. Hellkamp, N.A. Mark Estes, et al.. (2004). High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). Journal of the American College of Cardiology. 43(11). 2066–2071. 73 indexed citations
18.
Sweeney, Michael O., Anne S. Hellkamp, Kenneth A. Ellenbogen, et al.. (2003). Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction. Circulation. 107(23). 2932–2937. 1156 indexed citations breakdown →
19.
Alexander, Karen P., L. Kristin Newby, Anne S. Hellkamp, et al.. (2001). Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. Journal of the American College of Cardiology. 38(1). 1–7. 90 indexed citations
20.
Davidson, Michael G., et al.. (1993). Refractive state of aphakic and pseudophakic eyes of dogs. American Journal of Veterinary Research. 54(1). 174–177. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Bjerring Olesen Breakdown of academic impact, for papers by Michiel Rienstra Breakdown of academic impact, for papers by Laurent Fauchier Breakdown of academic impact, for papers by Mauro Moscucci Breakdown of academic impact, for papers by Morten Lock Hansen Breakdown of academic impact, for papers by John H. McAnulty Breakdown of academic impact, for papers by Shun Kohsaka Breakdown of academic impact, for papers by Jesper Lindhardsen Breakdown of academic impact, for papers by Islam Y. Elgendy Breakdown of academic impact, for papers by Tami L. Bair
Rankless by CCL
2026